The ESTIV Members AreaEPAA ANNUAL CONFERENCE 2021
The annual EPAA event will give participants insight into EPAA’s achievements in 2021, announce the EPAA Refinement Prize winner, and discuss our role in the EU chemical strategy for sustainability.
ESTIV Poster Award at the 2021 edition of the JRC Summer School has been granted to Sabrina Madiedo-Podvršan . Copy
Congratulations to the ESTIV Poster Award at the 2021 JRC Summer School on the Non-Animal Approaches in Science!
ESTIV Best Poster Award at the 11th World Congress on Alternatives and Animal Use in the Life Sciences has been granted to three excellent young scientists !
Three excellent poster presentations of early-career scientists have been selected by the WC11 ESTIV Awards committee taking into account scientific excellence, innovation and clarity of the poster presentations.
Modelling the pathogenesis of COVID-19 using the Adverse Outcome Pathway framework (CIAO) – online webinar
The CIAO project is helping to make sense of the enormous amount of biological information on COVID-19 by exploiting a well-established knowledge framework called Adverse Outcome Pathways (AOP).
WC11 Podcast – with Dr. Sandra Coecke, the recipient of the Björn Ekwall Memorial Award for the year 2020/2021
Dr. Sandra Coecke, the recipient of the Björn Ekwall Memorial Award for the year 2020, gave recently an interview for WC11 podcast…
The OECD gives the green light to the fish cell line assay!
The OECD gives the green light to the fish cell line assay. The new OECD guideline 249 allows companies to use fish cell line testing for product development and as part of the dossiers for chemical approval.
OECD has published new guidelines
We are excited to share, that OECD has published new important guidelines: OECD Guideline 497 and 498 related to sensitisation and phototoxicity!
May ESTIV-ASCCT Webinar: New Approach Methods in genotoxicity and mechanistic toxicity testing for the animal-free safety assessment of novel pharmaceuticals and chemicals
Every year, large numbers of new compounds are being developed for a wide range of purposes…..
The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research
To promote more human relevant research, the JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) led a study to review advanced non-animal models used in the field of neurodegenerative diseases, specifically for Parkinson’s and Alzheimer’s.
Silver Sponsor
Corporate Members
Memorandum of Understanding
